|
US 11,986,497 B2 |
|
| Immunotherapy against neuronal and brain tumors |
| Toni Weinschenk, Tuebingen (DE); Oliver Schoor, Tuebingen (DE); Claudia Trautwein, Tuebingen (DE); Norbert Hilf, Tuebingen (DE); Steffen Walter, Tuebingen (DE); and Harpreet Singh, Tuebingen (DE) |
| Assigned to Immatics Biotechnologies GmbH, (DE) |
| Filed by Immatics Biotechnologies GmbH, Tuebingen (DE) |
| Filed on Feb. 9, 2023, as Appl. No. 18/166,936. |
| Application 14/865,278 is a division of application No. 12/180,170, filed on Jul. 25, 2008, granted, now 9,175,040, issued on Nov. 3, 2015. |
| Application 18/166,936 is a continuation of application No. 16/891,841, filed on Jun. 3, 2020, granted, now 11,648,276. |
| Application 16/891,841 is a continuation of application No. 16/507,437, filed on Jul. 10, 2019, granted, now 10,709,735, issued on Jul. 14, 2020. |
| Application 16/507,437 is a continuation of application No. 16/196,402, filed on Nov. 20, 2018, granted, now 10,420,800, issued on Sep. 24, 2019. |
| Application 16/196,402 is a continuation of application No. 14/865,278, filed on Sep. 25, 2015, abandoned. |
| Claims priority of provisional application 60/953,161, filed on Jul. 31, 2007. |
| Claims priority of provisional application 61/041,129, filed on Mar. 31, 2008. |
| Claims priority of application No. 07014797 (EP), filed on Jul. 27, 2007; and application No. 08005889 (EP), filed on Mar. 27, 2008. |
| Prior Publication US 2023/0241111 A1, Aug. 3, 2023 |
| Int. Cl. C07K 7/06 (2006.01); A61K 35/17 (2015.01); A61K 39/00 (2006.01); C07K 7/08 (2006.01); C07K 14/47 (2006.01); C07K 14/495 (2006.01); C07K 14/725 (2006.01); C07K 16/40 (2006.01); C07K 19/00 (2006.01); C12N 5/0783 (2010.01); C12N 9/02 (2006.01); C12N 9/10 (2006.01); A61K 38/00 (2006.01) |